Focus: Drugmakers go under the skin, skirting early US Medicare price negotiations
[1/5]Pharmaceutical tablets and capsules are arranged in the shape of a U.S. dollar sign on a table in this picture illustration taken in Ljubljana August 20, 2014. REUTERS/Srdjan Zivulovic/File Photo NEW YORK, July 28 (Reuters) – Injectable versions of some widely-used cancer drugs including Johnson & Johnson’s (JNJ.N) blockbuster multiple myeloma treatment Darzalex are likely … Read more